Koumprentziotis IA, Cawley A, Ewig E, Gerard AO, et al. Dermatologic adverse events associated with Sacituzumab Govitecan: an
international retrospective study from the EADV Task Force "Dermatology for
Cancer Patients" and pharmacovigilance analysis. Breast Cancer Res Treat 2026;219:24.
PMID: 42804021
|